SCHEMBL14680970

SCHEMBL14680970

COCCN(C)c1ncc(-c2cccc(Nc3ccc(Cl)cn3)n2)o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 2/20 0.36
F10 P00742 3/20 0.36
RAB9A P51151 6/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
SLC2A1 P11166 1/20 0.33
PDE10A Q9Y233 1/20 0.32
NPC1 O15118 5/20 0.31
EDNRA P25101 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
SYK P43405 1/20 0.31
NFKB1 P19838 3/20 0.31
NFKB2 Q00653 3/20 0.31
RELA Q04206 3/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
KDM4E B2RXH2 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
MAPT P10636 1/20 0.31
XBP1 P17861 1/20 0.31
AHR P35869 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14684154 0.87 CCNT1 (0.33) CCNT1SYKDGAT1
SCHEMBL14680992 0.82 KARS1 (0.47) SLC2A1SYKDGAT1KDR
SCHEMBL14673963 0.80 FLT1 (0.39) CCNT1RAB9ASYKSMN1; SMN2DGAT1
SCHEMBL2228275 0.78 KDR (0.46) CCNT1MEN1KMT2ASLC2A1PDE10A
SCHEMBL2226110 0.76 SLC2A1 (0.44) RAB9AMEN1KMT2ASLC2A1NPC1
SCHEMBL2229276 0.71 KDR (0.46) RAB9AMEN1KMT2ASLC2A1NPC1
SCHEMBL2352796 0.69 GRM5 (0.41) CCNT1RAB9AMEN1KMT2ASLC2A1
SCHEMBL14673765 0.69 ABL1 (0.39) CCNT1F10CYP3A4
SCHEMBL2228280 0.68 MAPT (0.34) CCNT1RAB9AMEN1KMT2ASLC2A1
SCHEMBL4898748 0.68 SLC2A1 (0.50) RAB9AMEN1KMT2ASLC2A1PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-8962665-B2 Thiazole and oxazole kinase inhibitors AB SCIENCE (FR) 2015-02-24 US disclosed
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS AB SCIENCE (FR) 2013-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035331-A1 THIAZOLE AND OXAZOLE KINASE INHIBITORS SYK, LTK, MERTK CCNT1 2633/4885F10 3957/4885RAB9A 4453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.